Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations

Remme, 1994, Therapeutic strategies and neurohormonal control in heart failure, Eur Heart J, 15, 129, 10.1093/eurheartj/15.suppl_D.129 Cleland, 1998, Successes and failures of current treatment of heart failure, Lancet, 352, SI19, 10.1016/S0140-6736(98)90015-0 1987, Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS), N Engl J Med, 316, 1429, 10.1056/NEJM198706043162301 1991, Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure, N Engl J Med, 325, 293, 10.1056/NEJM199108013250501 Pitt, 1999, The effect of spironolactone on morbidity and mortality in patients with severe heart failure, N Engl J Med, 341, 709, 10.1056/NEJM199909023411001 1999, The Cardiac Insufficiency Bisoprolol Study II (CIBIS II): a randomised trial, Lancet, 353, 9, 10.1016/S0140-6736(98)11181-9 1999, Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF), Lancet, 353, 2001, 10.1016/S0140-6736(99)04440-2 Kornowski, 1995, Intensive home-care surveillance prevents hospitalization and improves morbidity rates among elderly patients with severe congestive heart failure, Am Heart J, 129, 762, 10.1016/0002-8703(95)90327-5 Rich, 1995, A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure, N Engl J Med, 333, 1190, 10.1056/NEJM199511023331806 Stevenson, 1989, Efficacy of medical therapy tailored for severe congestive heart failure in patients transferred for urgent cardiac transplantation, Am J Cardiol, 63, 461, 10.1016/0002-9149(89)90320-2 Steimle, 1997, Sustained hemodynamic efficacy of therapy tailored to reduce filling pressures in survivors with advanced heart failure, Circulation, 96, 1165, 10.1161/01.CIR.96.4.1165 Reis, 1997, Treatment of patients admitted to the hospital with congestive heart failure: specialty-related disparities in practice patterns and outcomes, J Am Coll Cardiol, 30, 733, 10.1016/S0735-1097(97)00214-3 van Veldhuisen, 1999, Differences in drug treatment of chronic heart failure between European countries, Eur Heart J, 20, 666, 10.1053/euhj.1998.1343 Cohn, 1984, Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure, N Engl J Med, 311, 819, 10.1056/NEJM198409273111303 Francis, 1993, Plasma norepinephrine, plasma renin activity, and congestive heart failure: relations to survival and the effects of therapy in V-HeFT II. The V-HeFT VA Cooperative Studies Group, Circulation, 87, 40 Schrier, 1999, Mechanisms of disease: hormones and hemodynamics in heart failure, N Engl J Med, 341, 577, 10.1056/NEJM199908193410806 Yasue, 1994, Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure, Circulation, 90, 195, 10.1161/01.CIR.90.1.195 Hunt, 1997, The role of the circulation in processing pro-brain natriuretic peptide (proBNP) to amino-terminal BNP and BNP-32, Peptides, 18, 1475, 10.1016/S0196-9781(97)00245-3 Richards, 1998, Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction, Circulation, 97, 1921, 10.1161/01.CIR.97.19.1921 Richards, 1999, Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction. The Christchurch Cardioendocrine Research Group, Heart, 81, 114, 10.1136/hrt.81.2.114 Kinnunen, 1993, Mechanisms of atrial and brain natriuretic peptide release from rat ventricular myocardium: effect of stretching, Endocrinology, 132, 1961, 10.1210/endo.132.5.8477647 Richards, 1993, Brain natriuretic factor: regional plasma concentrations and correlations with haemodynamic state in cardiac disease, Br Heart J, 69, 414, 10.1136/hrt.69.5.414 Magga, 1998, B-type natriuretic peptide: a myocyte-specific marker for characterizing loadinduced alterations in cardiac gene expression, Ann Med, 30, 39 Davis, 1994, Plasma brain natriuretic peptide in assessment of acute dyspnoea, Lancet, 343, 440, 10.1016/S0140-6736(94)92690-5 Murdoch, 1999, Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy, Am Heart J, 138, 1126, 10.1016/S0002-8703(99)70079-7 Ho, 1993, The epidemiology of heart failure: the Framingham Study, J Am Coll Cardiol, 22, 6A, 10.1016/0735-1097(93)90455-A Doughty, 1995, Hospital admissions and deaths due to congestive heart failure in New Zealand, 1988–91, N Z Med J, 108, 473 Cohn, 1997, Effect of the calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril: V-HeFT III—Vasodilator-Heart Failure Trial (V-HeFT) Study Group, Circulation, 96, 856, 10.1161/01.CIR.96.3.856 Domanski, 1999, Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction: a meta-analysis of randomized clinical trials, J Am Coll Cardiol, 33, 598, 10.1016/S0735-1097(98)00609-3